Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease.

Taylor, K M; Jagannath, S; Spitzer, G; Spinolo, J A; Tucker, S L; Fogel, B; Cabanillas, F F; Hagemeister, F B; Souza, L M

Taylor, K M; Jagannath, S; Spitzer, G; Spinolo, J A; Tucker, S L; Fogel, B; Cabanillas, F F; Hagemeister, F B; Souza, L M.

Affiliation

Taylor KM; Department of Hematology, M.D. Anderson Cancer Center, University of Texas, Houston 77030.

J Clin Oncol ; 7(12): 1791-9, 1989 Dec.

Article in En | MEDLINE | ID: mdl-2479719

Subject(s)

Bone Marrow Transplantation; Colony-Stimulating Factors/therapeutic use; Hematopoiesis/drug effects; Hodgkin Disease/therapy; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carmustine/administration & dosage; Colony-Stimulating Factors/adverse effects; Colony-Stimulating Factors/pharmacokinetics; Cyclophosphamide/administration & dosage; Drug Evaluation; Etoposide/administration & dosage; Granulocyte Colony-Stimulating Factor; Granulocytes/cytology; Hodgkin Disease/drug therapy; Hodgkin Disease/surgery; Humans; Leukocyte Count; Platelet Count/drug effects; Recombinant Proteins

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / Bone Marrow Transplantation / Colony-Stimulating Factors / Hematopoiesis Limits: Humans Language: En Journal: J Clin Oncol Year: 1989 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links